SYNTELLIX

Syntellix has achieved to develop what universities have failed at for more than a century and industrial conglomerates for more than three decades. The company's innovative MAGNEZIX® implants combine proven bioabsorbability with metallic strength and stability based on a patented magnesium platform technology. Its key implant has been granted Breakthrough Device designation by the U.S. FDA, and per 2020, Syntellix is the only company in the world with product registrations for a bioabsorbable ... metallic implant for orthopaedic and trauma use in several global top notch product registration systems. The company already marketed tens of thousands of medical implants and has achieved product approvals in more than 65 countries on five continents. Syntellix is now in transition from the phase of innovation, pioneering and creating a global footprint to execution and marketeering in order to further revolutionize health care and unleash its full potential as the Protagonist of the Era of Magnesium.More